Evidence map›Paper›PMID 35786084›Full record

ArticleAnnals of medicine2022

Nocturnal hypoxemia, blood pressure, vascular status and chronic mountain sickness in the highest city in the world.

Elisa Perger, Sébastien Baillieul, François Esteve, Aurélien Pichon, Gzregorz Bilo, Davide Soranna, Stéphane Doutreleau, Yann Savina, Mathilde Ulliel-Roche, Julien V Brugniaux and 9 more

Open access · goldAbstract read
In one paragraph

Article in Annals of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Advancing high-altitude medicine: a model for the future.Signal transduction and targeted therapy · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. [Current Status and Prospects of Research on Altitude-Related Hypertension].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 6 countries.

Elisa PergerIstituto Auxologico Italiano, IRCCS, Sleep Disorders Center & Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy.
Sébastien BaillieulUniv. Grenoble Alpes, HP2 Laboratory, INSERM U1300, CHU Grenoble Alpes, Grenoble, France.
François EsteveInserm UA7, Rayonnement Synchrotron pour la Recherche Biomédicale, Grenoble, France.
Aurélien PichonFaculty of Sport Sciences, Université de Poitiers, Laboratory Mobility, aging & exercise (MOVE, EA6314), Poitiers, France.
Gzregorz BiloIstituto Auxologico Italiano, IRCCS, Sleep Disorders Center & Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy.
Davide SorannaIstituto Auxologico Italiano, IRCCS, Biostatistics unit, Milan, Italy.
Stéphane DoutreleauUniv. Grenoble Alpes, HP2 Laboratory, INSERM U1300, CHU Grenoble Alpes, Grenoble, France.
Yann SavinaUniv. Grenoble Alpes, HP2 Laboratory, INSERM U1300, CHU Grenoble Alpes, Grenoble, France.
Mathilde Ulliel-RocheUniv. Grenoble Alpes, HP2 Laboratory, INSERM U1300, CHU Grenoble Alpes, Grenoble, France.
Julien V BrugniauxUniv. Grenoble Alpes, HP2 Laboratory, INSERM U1300, CHU Grenoble Alpes, Grenoble, France.
Emeric StaufferInteruniversity Laboratory of Human Movement Biology (LIBM, EA7424), "Red Blood cell and Vascular Biology" team, Univ Lyon - University Claude Bernard Lyon 1, Villeurbanne, France.
Laura OberholzerDepartment of Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway.
Connor HoweCentre for Heart, Lung, and Vascular Health, University of British Columbia, Kelowna, Canada.
Ivan HanncoUniv. Grenoble Alpes, HP2 Laboratory, INSERM U1300, CHU Grenoble Alpes, Grenoble, France.
Carolina LombardiIstituto Auxologico Italiano, IRCCS, Sleep Disorders Center & Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy.
Renaud TamisierUniv. Grenoble Alpes, HP2 Laboratory, INSERM U1300, CHU Grenoble Alpes, Grenoble, France.
Jean-Louis PepinUniv. Grenoble Alpes, HP2 Laboratory, INSERM U1300, CHU Grenoble Alpes, Grenoble, France.
Samuel VergesUniv. Grenoble Alpes, HP2 Laboratory, INSERM U1300, CHU Grenoble Alpes, Grenoble, France.
Gianfranco ParatiIstituto Auxologico Italiano, IRCCS, Sleep Disorders Center & Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy.
Université Grenoble Alpes · FRCentre Hospitalier Universitaire de Grenoble · FRIRCCS Istituto Auxologico Italiano · ITBritish Heart Foundation · GBInserm · FRIstituti di Ricovero e Cura a Carattere Scientifico · ITLaboratoire Interuniversitaire de Biologie de la Motricité · FRNorwegian School of Sport Sciences · NOSynchrotron Radiation for BiomedicineUniversité de Poitiers · FRUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionChronic mountain sickness (CMS) is a condition characterized by excessive erythrocytosis in response to chronic hypobaric hypoxia. CMS frequently triggers cardiorespiratory diseases such as pulmonary hypertension and right or left heart failure. Ambient hypoxia might be further amplified night-time by intermittent hypoxia related to sleep-disordered breathing (SDB) so that sleep disturbance may be an important feature of CMS. Our aim was to characterize in a cross-sectional study nocturnal hypoxaemia, SDB, blood pressure (BP), arterial stiffness and carotid intima-media thickness (CIMT) in highlanders living at extreme altitude.

methodsMen aged 18 to 55 years were prospectively recruited. Home sleep apnoea test, questionnaires (short-form health survey; Montreal cognitive assessment; Pittsburgh Sleep Questionnaire Index and the Insomnia severity index), 24-h ambulatory BP monitoring, CIMT and arterial stiffness were evaluated in 3 groups: i) Andean lowlanders (sea-level); ii) highlanders living at 3,800 m and iii) highlanders living at 5,100 m. Analyses were conducted in sub-groups according to 1) CMS severity 2) healthy subjects living at the three different altitude.

resultsNinety-two males were evaluated at their living altitudes. Among the 54 highlanders living at 5,100 m, subjects with CMS showed lower mean nocturnal oxygen saturation (SpO

conclusionsLower nocturnal SpO

Indexed as

Altitude SicknessHypertensionSleep Apnea SyndromesBlood PressureCarotid Intima-Media ThicknessChronic DiseaseCross-Sectional StudiesHumansHypoxiaMalePulse Wave AnalysisQuality of Lifeblood pressure variabilitychronic mountain sicknesshigh-altitudeHypoxiasleep apnoeasleep disordered breathing

Identifiers

PMID35786084
PMCPMC9258438
OpenAlexW4283810177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.